Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

The ABCs of RCTs

Jason Liebowitz, MD, FACR  |  Issue: March 2025  |  December 4, 2024

More and more, clinicians have a growing number of possible treatments available to choose from, but lack evidence to guide those decisions. This situation prompted the development of the Sequential, Multiple Assignment, Randomized Trial (SMART), in which sequential steps are adapted to a patient’s individual response, subjects are randomized to feasible options at key decision points in which equipoise is achieved, and evolving characteristics—beyond just baseline characteristics—are collected between and at decision points.

To illustrate this model, Dr. Schanberg discussed a trial that would seek to treat patients with juvenile idiopathic arthritis who have had inadequate response to a tumor necrosis factor (TNF) alpha inhibitor. At decision point #1 (i.e., at initial TNF-alpha failure), the participant can either be treated with a different TNF-alpha inhibitor or receive medication with a different mechanism of action. At decision point #2 (i.e., after 3–6 months of the initial treatment), responders could be continued on treatment and non-responders could be switched to a new non-TNF-alpha biologic.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The SMART design for a clinical trial is meant to mimic what which would occur in real-life and create a plan for how patients within a trial will be treated depending on their course and response—or lack of response—to a treatment within a trial.

Dr. Schanberg noted several potential benefits to SMART design of clinical trials, including the ability to target a range of scientific questions, the ability to use smaller sample sizes of participants and still yield important outcomes data, and yield scientific insights that are highly relevant to clinical practice.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

In Sum

The session was full of wisdom for those willing to modify classic models of RCT design. With more talks like these, the RCT space is likely to continue to evolve—and improve—in the coming years.


Dr. Jason Liebowitz

Jason Liebowitz, MD, is an assistant professor of medicine in the Division of Rheumatology at Columbia University Vagelos College of Physicians and Surgeons, New York.

 

 

Reference

  1. Allen KD, Woolson S, Hoenig HM, et al. Stepped exercise program for patients with knee osteoarthritis: A randomized controlled trial. Ann Intern Med. 2021 Mar;174(3):298–307.

Page: 1 2 3 | Single Page
Share: 

Filed under:ACR ConvergenceGuidanceMeeting Reports Tagged with:ACR Convergence 2024Clinical researchdatarandomized clinical trials

Related Articles

    Nancy Bates Allen, MD, in the Spotlight

    September 11, 2020

    Nancy Bates Allen, MD, now professor emeritus, Duke University Medical School, Division of Rheuma­tology and Immunology, Durham, N.C., created a legacy of clinical care, clinical research, advocacy for women and collegial respect during her 42-year career at Duke. David S. Caldwell, MD, FACP, FACR, associate professor of medicine, Duke University School of Medicine, says, “[I’m]…

    Mitigate Risk and Increase Success of Lupus Clinical Trials

    August 1, 2010

    Design strategies from a Lupus Research Institute conference

    Physical Activity, Exercise Can Benefit Patients with RA

    November 9, 2017

    While medical advances in rheumatoid arthritis (RA) have led to improvements in disease control and quality of life for patients worldwide, the rate for stable remission remains low.1 Management of RA symptoms is traditionally accomplished through a combination of medications and nonpharmacological interventions.2 This approach can prevent the development of secondary adverse health outcomes. Two…

    Why & How to Pursue Shared Decision Making with Your Patients

    June 21, 2018

    Over the past several decades, the medical community has been moving toward a model of shared decision making. In addition to its ethical advantages, shared decision making potentially yields such benefits as improved medical adherence and better health outcomes. With the proliferation of treatment options and changes in the larger culture, shared decision making is…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences